US Stock MarketDetailed Quotes

MRSN Mersana Therapeutics

Watchlist
  • 0.517
  • +0.037+7.79%
Trading Mar 4 14:34 ET
64.48MMarket Cap-0.92P/E (TTM)

Mersana Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
9.88%40.5M
52.89%16.36M
63.65%12.6M
-78.48%2.29M
18.50%9.25M
38.65%36.86M
-27.14%10.7M
38.13%7.7M
148.69%10.65M
283.20%7.8M
Operating revenue
9.88%40.5M
52.89%16.36M
63.65%12.6M
-78.48%2.29M
18.50%9.25M
38.65%36.86M
-27.14%10.7M
38.13%7.7M
148.69%10.65M
283.20%7.8M
Cost of revenue
Gross profit
Operating expense
-45.22%113.83M
-1.44%31.17M
-43.20%24.67M
-58.68%27.75M
-53.90%30.25M
-9.78%207.81M
-47.73%31.63M
-33.41%43.43M
19.85%67.16M
35.02%65.6M
Selling and administrative expenses
-31.46%40.81M
-12.31%8.89M
-23.50%9.86M
-42.25%10.5M
-36.93%11.56M
4.53%59.54M
-31.55%10.13M
-11.52%12.89M
22.86%18.19M
43.39%18.33M
-General and administrative expense
-31.46%40.81M
-12.31%8.89M
-23.50%9.86M
-42.25%10.5M
-36.93%11.56M
4.53%59.54M
-31.55%10.13M
-11.52%12.89M
22.86%18.19M
43.39%18.33M
Research and development costs
-50.75%73.02M
3.68%22.29M
-51.51%14.8M
-64.78%17.25M
-60.47%18.69M
-14.49%148.27M
-52.97%21.5M
-39.71%30.53M
18.77%48.97M
32.03%47.28M
Operating profit
57.10%-73.34M
29.23%-14.81M
66.22%-12.07M
54.95%-25.46M
63.67%-21M
16.10%-170.96M
54.33%-20.93M
40.09%-35.73M
-9.18%-56.5M
-24.16%-57.8M
Net non-operating interest income expense
-42.98%4.56M
-63.14%694K
-56.85%986K
-45.90%1.19M
3.48%1.7M
1,897.75%8M
108.76%1.88M
1,428.49%2.29M
567.80%2.19M
332.01%1.64M
Non-operating interest income
-30.13%8.44M
-45.51%1.6M
-40.28%1.97M
-32.59%2.17M
2.90%2.7M
318.77%12.07M
57.07%2.93M
366.38%3.3M
1,006.19%3.22M
14,461.11%2.62M
Non-operating interest expense
-4.89%3.87M
-13.84%903K
-3.05%986K
-4.10%983K
1.93%1M
22.39%4.07M
8.71%1.05M
15.57%1.02M
34.87%1.03M
35.77%983K
Other net income (expense)
-8.71M
-499K
-8.21M
Special income (charges)
--0
--0
--0
----
----
---8.71M
---499K
---8.21M
----
----
-Less：Restructuring and merger&acquisition
--0
--0
--0
----
----
--8.71M
--499K
--8.21M
----
----
Income before tax
59.94%-68.77M
27.77%-14.12M
73.39%-11.08M
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
Income tax
418K
0
418K
0
0
0
Net income
59.69%-69.19M
27.77%-14.12M
72.39%-11.5M
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
Net income continuous Operations
59.69%-69.19M
27.77%-14.12M
72.39%-11.5M
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
Minority interest income
Net income attributable to the parent company
59.69%-69.19M
27.77%-14.12M
72.39%-11.5M
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
59.69%-69.19M
27.77%-14.12M
72.39%-11.5M
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
Basic earnings per share
62.16%-0.56
31.25%-0.11
74.29%-0.09
57.45%-0.2
69.23%-0.16
32.11%-1.48
63.64%-0.16
42.62%-0.35
14.55%-0.47
11.86%-0.52
Diluted earnings per share
62.16%-0.56
31.25%-0.11
74.29%-0.09
57.45%-0.2
69.23%-0.16
32.11%-1.48
63.64%-0.16
42.62%-0.35
14.55%-0.47
11.86%-0.52
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 9.88%40.5M52.89%16.36M63.65%12.6M-78.48%2.29M18.50%9.25M38.65%36.86M-27.14%10.7M38.13%7.7M148.69%10.65M283.20%7.8M
Operating revenue 9.88%40.5M52.89%16.36M63.65%12.6M-78.48%2.29M18.50%9.25M38.65%36.86M-27.14%10.7M38.13%7.7M148.69%10.65M283.20%7.8M
Cost of revenue
Gross profit
Operating expense -45.22%113.83M-1.44%31.17M-43.20%24.67M-58.68%27.75M-53.90%30.25M-9.78%207.81M-47.73%31.63M-33.41%43.43M19.85%67.16M35.02%65.6M
Selling and administrative expenses -31.46%40.81M-12.31%8.89M-23.50%9.86M-42.25%10.5M-36.93%11.56M4.53%59.54M-31.55%10.13M-11.52%12.89M22.86%18.19M43.39%18.33M
-General and administrative expense -31.46%40.81M-12.31%8.89M-23.50%9.86M-42.25%10.5M-36.93%11.56M4.53%59.54M-31.55%10.13M-11.52%12.89M22.86%18.19M43.39%18.33M
Research and development costs -50.75%73.02M3.68%22.29M-51.51%14.8M-64.78%17.25M-60.47%18.69M-14.49%148.27M-52.97%21.5M-39.71%30.53M18.77%48.97M32.03%47.28M
Operating profit 57.10%-73.34M29.23%-14.81M66.22%-12.07M54.95%-25.46M63.67%-21M16.10%-170.96M54.33%-20.93M40.09%-35.73M-9.18%-56.5M-24.16%-57.8M
Net non-operating interest income expense -42.98%4.56M-63.14%694K-56.85%986K-45.90%1.19M3.48%1.7M1,897.75%8M108.76%1.88M1,428.49%2.29M567.80%2.19M332.01%1.64M
Non-operating interest income -30.13%8.44M-45.51%1.6M-40.28%1.97M-32.59%2.17M2.90%2.7M318.77%12.07M57.07%2.93M366.38%3.3M1,006.19%3.22M14,461.11%2.62M
Non-operating interest expense -4.89%3.87M-13.84%903K-3.05%986K-4.10%983K1.93%1M22.39%4.07M8.71%1.05M15.57%1.02M34.87%1.03M35.77%983K
Other net income (expense) -8.71M-499K-8.21M
Special income (charges) --0--0--0-----------8.71M---499K---8.21M--------
-Less：Restructuring and merger&acquisition --0--0--0----------8.71M--499K--8.21M--------
Income before tax 59.94%-68.77M27.77%-14.12M73.39%-11.08M55.31%-24.27M65.63%-19.31M15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M
Income tax 418K0418K000
Net income 59.69%-69.19M27.77%-14.12M72.39%-11.5M55.31%-24.27M65.63%-19.31M15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M
Net income continuous Operations 59.69%-69.19M27.77%-14.12M72.39%-11.5M55.31%-24.27M65.63%-19.31M15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M
Minority interest income
Net income attributable to the parent company 59.69%-69.19M27.77%-14.12M72.39%-11.5M55.31%-24.27M65.63%-19.31M15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 59.69%-69.19M27.77%-14.12M72.39%-11.5M55.31%-24.27M65.63%-19.31M15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M
Basic earnings per share 62.16%-0.5631.25%-0.1174.29%-0.0957.45%-0.269.23%-0.1632.11%-1.4863.64%-0.1642.62%-0.3514.55%-0.4711.86%-0.52
Diluted earnings per share 62.16%-0.5631.25%-0.1174.29%-0.0957.45%-0.269.23%-0.1632.11%-1.4863.64%-0.1642.62%-0.3514.55%-0.4711.86%-0.52
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Taiwan Semiconductor
TSM
+4.96%
Advanced Micro Devices
AMD
+3.33%
Alphabet-C
GOOG
+3.19%
Alphabet-A
GOOGL
+3.12%
NVIDIA
NVDA
+2.90%

Unlock the Full List